Incidence of Australia antigen in patients with acute virus hepatitis and chronic hepatic disorders following virus hepatitis in our records
Patorska-Mach, E.; Pieciński, Z.; Siuciak, J.
Polski Tygodnik Lekarski 27(50): 1975-1977
1972
ISSN/ISBN: 0032-3756 PMID: 4649227 Document Number: 46639
Document emailed within 1 workday
Related Documents
Buligescu, L.; Lenkei, R.; Dumitriu, M.; Focşeneanu, V. 1973: Study of Australia antigen in chronic hepatitis, hepatic cirrhosis and acute hepatitis cured without defect Medicina Interna 25(6): 699-710Kakumu, S.; Ishikawa, T.; Wakita, T.; Yoshioka, K.; Takayanagi, M.; Tahara, H.; Kusakabe, A. 1994: Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B American Journal of Gastroenterology 89(1): 92-96
Boroń, P.; Kossakowski, R.; Sokolewicz, E. 1971: Incidence of so-called Australia antigen (Au I) in children with virus hepatitis Pediatria Polska 46(1): 1-6
Naveau, S.; Delfraissy, J.F.; Poitrine, A.; Poynard, T.; Chaput, J.C. 1985: Simultaneous detection of IgM antibodies against the hepatitis a virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis Gastroenterologie Clinique et Biologique 9(2): 109-112
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Simon, P.; Menault, M.; Tanquerel, T.; Herry, D. 1978: B virus chronic hepatitis in the haemodialysed uraemic patient. Correlation between hepatic lesions and the presence of antigen e in 12 patients La Nouvelle Presse Medicale 7(32): 2837-2840
Laufer, N.; Cassino, L.; Bolcic, F.; Moretti, F.; Reynoso, R.; Bouzas, M.B.; Cahn, P.; Salomón, H.; Quarleri, J. 2008: Uncommon hepatitis B virus and/or hepatitis C virus occult infection in HIV-positive patients with abnormal level of hepatic enzyme Journal of Acquired Immune Deficiency Syndromes 49(2): 233-234
Iroezindu, M.O.; Daniyam, C.A.; Agbaji, O.O.; Isa, E.S.; Okeke, E.N.; Imade, G.E. 2013: Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria Journal of Infection in Developing Countries 7(12): 951-959
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
Nielsen, J.O.; Dietrichson, O.; Juhl, E. 1974: Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme Lancet 2(7886): 913-915
El-Sayed, N.M.; el-Halawani, T.A. 1995: Comparative study of serum and salivary hepatitis B surface antigen and hepatitis C antibodies among patients infected with hepatitis B or C virus Egyptian Dental Journal 41(3): 1305-1312
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Saravanan, S.; Velu, V.; Nandakumar, S.; Madhavan, V.; Shanmugasundaram, U.; Murugavel, K.G.; Balakrishnan, P.; Kumarasamy, N.; Solomon, S.; Thyagarajan, S.P. 2009: Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease Journal of Microbiology Immunology and Infection 42(2): 122-128
Farkas, E. 1970: The Australia antigen and the hepatitis virus Orvosi Hetilap 111(15): 843-846
Sonnabend, W.; Kistler, G.S.; Thiel, G.; Zollinger, H.U.; Bianchi, L.; Enderlin, F.; Gudat, F.; Krech, U. 1974: Chronic focal glomerulonephritis and chronic persistent hepatitis following kidney transplantation. Detection of Hepatitis B and Epstein-Barr virus antigen Schweizerische Medizinische Wochenschrift 104(35): 1205-1217
Bartolomé, J.; Castillo, I.; Mora, I.; Gutiez, J.; Porres, J.C.; Carreño, V. 1988: Different levels of hepatitis B virus replication among hepatitis be antigen-positive chronic carriers Acta Virologica 32(3): 193-197
Huang, Y.; Wu, G.; Wang, X. 1995: Analysis of hepatitis B virus X antigen expression in chronic hepatitis B and cirrhosis Zhonghua Nei Ke Za Zhi 34(4): 235-238
Perrillo, R.P.; Brunt, E.M. 1991: Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen Annals of Internal Medicine 115(2): 113-115
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354